Clonidine used as a perineural adjuvant to ropivacaine, does not prolong the duration of sensory block when controlling for systemic effects: A paired, blinded, randomized trial in healthy volunteers.

Jakob Hessel AndersenPia JaegerTobias Laier SonneJørgen Berg DahlOle MathiesenUlrik Grevstad

Published in: PloS one (2017)

Administering clonidine perineurally as an adjuvant to ropivacaine in an ACB did not prolong the duration of sensory block in a setup controlling for systemic effects of clonidine.

Keyphrases

early stage
study protocol
randomized controlled trial
clinical trial
drug induced
placebo controlled